Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Firefly Neuroscience (AIFF) Current Leases (2019 - 2024)

Firefly Neuroscience has reported Current Leases over the past 6 years, most recently at $39610.0 for Q2 2024.

  • Quarterly results put Current Leases at $39610.0 for Q2 2024, down 81.58% from a year ago — trailing twelve months through Jun 2024 was $39610.0 (down 81.58% YoY), and the annual figure for FY2023 was $163282.0, down 19.7%.
  • Current Leases for Q2 2024 was $39610.0 at Firefly Neuroscience, down from $78778.0 in the prior quarter.
  • Over the last five years, Current Leases for AIFF hit a ceiling of $218695.0 in Q3 2023 and a floor of $18008.0 in Q2 2021.
  • Median Current Leases over the past 5 years was $134739.5 (2020), compared with a mean of $128463.1.
  • Biggest five-year swings in Current Leases: crashed 82.71% in 2021 and later surged 1008.14% in 2022.
  • Firefly Neuroscience's Current Leases stood at $45595.0 in 2020, then skyrocketed by 321.38% to $192128.0 in 2021, then grew by 5.84% to $203342.0 in 2022, then fell by 19.7% to $163282.0 in 2023, then plummeted by 75.74% to $39610.0 in 2024.
  • The last three reported values for Current Leases were $39610.0 (Q2 2024), $78778.0 (Q1 2024), and $163282.0 (Q4 2023) per Business Quant data.